Thrivent Financial for Lutherans
UTHR icon

Thrivent Financial for Lutherans’s United Therapeutics UTHR Stock Holding History

Thrivent Financial for Lutherans’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.7M Buy
128,626
+22,186
+21% +$12.5M 0.12% 209
2026
Q1 		$63.1M Sell
106,440
-14,362
-12% -$7.15M 0.12% 207
2025
Q4 		$58.9M Sell
120,802
-55,985
-32% -$26.1M 0.1% 235
2025
Q3 		$74.1M Sell
176,787
-8,690
-5% -$2.92M 0.15% 169
2025
Q2 		$53.3M Sell
185,477
-20,154
-10% -$6.02M 0.12% 216
2025
Q1 		$63.4M Buy
205,631
+1,332
+0.7% +$456K 0.14% 197
2024
Q4 		$72.1M Buy
204,299
+189,967
+1,325% +$69.8M 0.14% 197
2024
Q3 		$5.14M Buy
14,332
+3,615
+34% +$1.22M 0.01% 910
2024
Q2 		$3.41M Sell
10,717
-1,060
-9% -$281K 0.01% 1056
2024
Q1 		$2.71M Buy
11,777
+52
+0.4% +$11.7K 0.01% 1198
2023
Q4 		$2.58M Sell
11,725
-27
-0.2% -$6.22K 0.01% 1215
2023
Q3 		$2.65M Sell
11,752
-340
-3% -$78.3K 0.01% 1111
2023
Q2 		$2.67M Buy
12,092
+64
+0.5% +$14.2K 0.01% 1162
2023
Q1 		$2.69M Sell
12,028
-112
-0.9% -$27.6K 0.01% 1100
2022
Q4 		$3.38M Buy
12,140
+93
+0.8% +$23.5K 0.01% 952
2022
Q3 		$2.52M Buy
12,047
+162
+1% +$36.2K 0.01% 1091
2022
Q2 		$2.8M Buy
11,885
+116
+1% +$23.6K 0.01% 1047
2022
Q1 		$2.11M Sell
11,769
-106
-0.9% -$20.2K ﹤0.01% 1292
2021
Q4 		$2.57M Buy
11,875
+141
+1% +$27.7K ﹤0.01% 1228
2021
Q3 		$2.17M Sell
11,734
-158
-1% -$31.1K ﹤0.01% 1296
2021
Q2 		$2.13M Sell
11,892
-13,156
-53% -$2.51M ﹤0.01% 1388
2021
Q1 		$4.19M Sell
25,048
-13,013
-34% -$2.17M 0.01% 989
2020
Q4 		$5.78M Buy
38,061
+8,618
+29% +$1.13M 0.01% 808
2020
Q3 		$2.97M Sell
29,443
-980
-3% -$108K 0.01% 972
2020
Q2 		$3.68M Sell
30,423
-25,178
-45% -$2.83M 0.01% 806
2020
Q1 		$5.27M Buy
55,601
+5,341
+11% +$508K 0.02% 641
2019
Q4 		$4.43M Buy
50,260
+38,875
+341% +$3.42M 0.01% 766
2019
Q3 		$908K Sell
11,385
-173
-1% -$13.9K ﹤0.01% 1469
2019
Q2 		$902K Buy
11,558
+256
+2% +$23.9K ﹤0.01% 1477
2019
Q1 		$1.33M Buy
11,302
+242
+2% +$28.2K ﹤0.01% 1183
2018
Q4 		$1.2M Buy
11,060
+630
+6% +$73K ﹤0.01% 1053
2018
Q3 		$1.33M Buy
10,430
+509
+5% +$63K ﹤0.01% 1108
2018
Q2 		$1.12M Buy
9,921
+69
+0.7% +$7.58K ﹤0.01% 1192
2018
Q1 		$1.11M Buy
9,852
+521
+6% +$66.2K ﹤0.01% 1183
2017
Q4 		$1.38M Sell
9,331
-9
-0.1% -$1.14K ﹤0.01% 1085
2017
Q3 		$1.09M Buy
9,340
+220
+2% +$28.1K ﹤0.01% 1123
2017
Q2 		$1.18M Buy
9,120
+690
+8% +$86.1K ﹤0.01% 1039
2017
Q1 		$1.14M Buy
8,430
+1,190
+16% +$180K ﹤0.01% 1095
2016
Q4 		$1.04M Buy
7,240
+420
+6% +$53.6K ﹤0.01% 1129
2016
Q3 		$805K Buy
6,820
+550
+9% +$66.1K ﹤0.01% 1226
2016
Q2 		$664K Buy
6,270
+560
+10% +$62.5K ﹤0.01% 1284
2016
Q1 		$636K Buy
5,710
+450
+9% +$56.9K ﹤0.01% 1272
2015
Q4 		$824K Buy
5,260
+110
+2% +$16K ﹤0.01% 1134
2015
Q3 		$676K Buy
5,150
+450
+10% +$72.2K ﹤0.01% 1087
2015
Q2 		$818K Buy
4,700
+1,000
+27% +$180K ﹤0.01% 895
2015
Q1 		$638K Hold
3,700
– – ﹤0.01% 998
2014
Q4 		$479K Hold
3,700
– – ﹤0.01% 1131
2014
Q3 		$476K Buy
3,700
+250
+7% +$25.8K ﹤0.01% 1132
2014
Q2 		$305K Sell
3,450
-150
-4% -$14.4K ﹤0.01% 1393
2014
Q1 		$339K Sell
3,600
-86,400
-96% -$8.84M ﹤0.01% 1174
2013
Q4 		$10.2M Buy
90,000
+34,100
+61% +$3.08M 0.06% 305
2013
Q3 		$4.41M Sell
55,900
-63,200
-53% -$4.62M 0.03% 454
2013
Q2 		$7.84M Buy
+119,100
New +$7.67M 0.05% 356

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Thrivent Financial for Lutherans's UTHR Position: Q2 2026 in Review

Thrivent Financial for Lutherans increased its United Therapeutics (UTHR) stake by 21% in Q2 2026, buying an estimated $12.5M and bringing the position to 128,626 shares worth $69.7M. The position accounts for 0.12% of the portfolio, ranked #209.

Thrivent Financial for Lutherans first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $74.1M in Q3 2025. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Thrivent Financial for Lutherans held 128,626 shares of United Therapeutics worth $69.7M as of Q2 2026.
  • Thrivent Financial for Lutherans bought 22,186 United Therapeutics shares in Q2 2026, an estimated $12.5M.
  • United Therapeutics made up 0.12% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #209 holding.
  • Thrivent Financial for Lutherans first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
  • Thrivent Financial for Lutherans's United Therapeutics position peaked at $74.1M in Q3 2025.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.